Guardant Health
GH
#1154
Rank
ยฃ14.94 B
Marketcap
ยฃ110.44
Share price
1.30%
Change (1 day)
51.93%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): -ยฃ2.61

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -ยฃ2.66. In 2025 the company made an earnings per share (EPS) of -ยฃ2.52 an increase over its 2024 EPS that were of -ยฃ2.71.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ2.613.79%
2025-ยฃ2.52-7.02%
2024-ยฃ2.71-16.82%
2023-ยฃ3.26-33.13%
2022-ยฃ4.8760%
2021-ยฃ3.0455.04%
2020-ยฃ1.96207.14%
2019-ยฃ0.64-19.81%
2018-ยฃ0.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-ยฃ0.19-92.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-ยฃ1.86-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA